Correction: TPL inhibits the invasion and migration of drug-resistant ovarian cancer by targeting the PI3K/AKT/NF-κB-signaling pathway to inhibit the polarization of M2 TAMs

[This corrects the article DOI: 10.3389/fonc.2021.704001.]. Keywords: A2780/DDP cells; PI3K/AKT/NF-κB- pathway; cisplatin (DDP)... ...